Literature DB >> 24421838

Successful management of nosocomial ventriculitis and meningitis caused by extensively drug-resistant Acinetobacter baumannii in Austria.

M Hoenigl1, M Drescher2, G Feierl3, T Valentin2, G Zarfel3, K Seeber2, R Krause2, Aj Grisold3.   

Abstract

Nosocomial infections caused by the Gram-negative coccobacillus Acinetobacter baumannii have substantially increased over recent years. Because Acinetobacter is a genus with a tendency to quickly develop resistance to multiple antimicrobial agents, therapy is often complicated, requiring the return to previously used drugs. The authors report a case of meningitis due to extensively drug-resistant A baumannii in an Austrian patient who had undergone neurosurgery in northern Italy. The case illustrates the limits of therapeutic options in central nervous system infections caused by extensively drug-resistant pathogens.

Entities:  

Keywords:  Acinetobacter baumannii; Colistin; Meningitis; Multidrug resistance

Year:  2013        PMID: 24421838      PMCID: PMC3852464          DOI: 10.1155/2013/613865

Source DB:  PubMed          Journal:  Can J Infect Dis Med Microbiol        ISSN: 1712-9532            Impact factor:   2.471


  21 in total

1.  Comparison of three different in vitro methods of detecting synergy: time-kill, checkerboard, and E test.

Authors:  R L White; D S Burgess; M Manduru; J A Bosso
Journal:  Antimicrob Agents Chemother       Date:  1996-08       Impact factor: 5.191

Review 2.  Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features.

Authors:  E Bergogne-Bérézin; K J Towner
Journal:  Clin Microbiol Rev       Date:  1996-04       Impact factor: 26.132

3.  Mortality and the increase in length of stay attributable to the acquisition of Acinetobacter in critically ill patients.

Authors:  J L García-Garmendia; C Ortiz-Leyba; J Garnacho-Montero; F J Jiménez-Jiménez; J Monterrubio-Villar; M Gili-Miner
Journal:  Crit Care Med       Date:  1999-09       Impact factor: 7.598

Review 4.  Multidrug-resistant Acinetobacter infections: an emerging challenge to clinicians.

Authors:  Rupali Jain; Larry H Danziger
Journal:  Ann Pharmacother       Date:  2004-07-27       Impact factor: 3.154

Review 5.  Nosocomial acinetobacter meningitis secondary to invasive procedures: report of 25 cases and review.

Authors:  Y Siegman-Igra; S Bar-Yosef; A Gorea; J Avram
Journal:  Clin Infect Dis       Date:  1993-11       Impact factor: 9.079

Review 6.  Intrathecal colistin for drug-resistant Acinetobacter baumannii central nervous system infection: a case series and systematic review.

Authors:  T Khawcharoenporn; A Apisarnthanarak; L M Mundy
Journal:  Clin Microbiol Infect       Date:  2009-08-17       Impact factor: 8.067

Review 7.  Current control and treatment of multidrug-resistant Acinetobacter baumannii infections.

Authors:  Drosos E Karageorgopoulos; Matthew E Falagas
Journal:  Lancet Infect Dis       Date:  2008-12       Impact factor: 25.071

Review 8.  Acinetobacter baumannii: an emerging opportunistic pathogen.

Authors:  Aoife Howard; Michael O'Donoghue; Audrey Feeney; Roy D Sleator
Journal:  Virulence       Date:  2012-05-01       Impact factor: 5.882

Review 9.  New treatment options against gram-negative organisms.

Authors:  Matteo Bassetti; Francesca Ginocchio; Malgorzata Mikulska
Journal:  Crit Care       Date:  2011-03-22       Impact factor: 9.097

10.  Colistin: recent data on pharmacodynamics properties and clinical efficacy in critically ill patients.

Authors:  Argyris S Michalopoulos; Matthew E Falagas
Journal:  Ann Intensive Care       Date:  2011-08-02       Impact factor: 6.925

View more
  3 in total

1.  International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti-infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP).

Authors:  Brian T Tsuji; Jason M Pogue; Alexandre P Zavascki; Mical Paul; George L Daikos; Alan Forrest; Daniele R Giacobbe; Claudio Viscoli; Helen Giamarellou; Ilias Karaiskos; Donald Kaye; Johan W Mouton; Vincent H Tam; Visanu Thamlikitkul; Richard G Wunderink; Jian Li; Roger L Nation; Keith S Kaye
Journal:  Pharmacotherapy       Date:  2019-01       Impact factor: 6.251

2.  Diversity of Oxacillinases and Sequence Types in Carbapenem-Resistant Acinetobacter baumannii from Austria.

Authors:  Andrea J Grisold; Josefa Luxner; Branka Bedenić; Magda Diab-Elschahawi; Michael Berktold; Agnes Wechsler-Fördös; Gernot E Zarfel
Journal:  Int J Environ Res Public Health       Date:  2021-02-23       Impact factor: 3.390

3.  Successful treatment of extensively drug-resistant Acinetobacter baumannii ventriculitis with polymyxin B and tigecycline- a case report.

Authors:  Wei Guo; Shao-Chun Guo; Min Li; Li-Hong Li; Yan Qu
Journal:  Antimicrob Resist Infect Control       Date:  2018-02-14       Impact factor: 4.887

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.